Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

IN BRIEF: Advanced Oncotherapy non-exec director buys 500,000 shares

30th Dec 2022 14:33

Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment - Non-Executive Director Michael Bradfield buys 500,000 shares at 13.17 pence, worth GBP65,825, on Thursday. Now has 8.4 million shares, a 1.6% stake.

Current stock price: 13.84p, closed up 4.5% on Friday in London

12-month change: down 63%

By Tom Waite, Alliance News editor

Comments and questions to [email protected]

Copyright 2022 Alliance News Ltd. All Rights Reserved.


Related Shares:

AVO.L
FTSE 100 Latest
Value8,809.74
Change53.53